ストックスクリーナーアプリを入手
20.28
2.27%
-0.47
前日終値:
$20.75
開ける：
$20.68
24時間の取引高:
2.57M
Relative Volume:
0.99
時価総額：
$2.90B
収益：
-
当期純損益:
$-412.89M
株価収益率:
-5.2539
EPS:
-3.86
ネットキャッシュフロー:
$-361.93M
1週間 パフォーマンス:
-7.40%
1か月 パフォーマンス:
-2.97%
6か月 パフォーマンス:
+44.96%
1年 パフォーマンス:
-26.89%
1日の値動き範囲:
$20.14
$21.00
1週間の範囲:
$19.45
$21.58
52週間の値動き範囲:
$6.36
$29.71
Dyne Therapeutics Inc Stock (DYN) Company Profile
DYN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DYN
Dyne Therapeutics Inc
|
20.28 | 2.95B | 0 | -412.89M | -361.93M | -3.86 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Dyne Therapeutics Inc Stock (DYN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-08-25 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2025-06-24 | 開始されました | Bernstein | Mkt Perform |
| 2025-06-11 | 再開されました | Raymond James | Outperform |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-05-29 | 開始されました | Evercore ISI | Outperform |
| 2025-03-12 | 開始されました | BMO Capital Markets | Outperform |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-12-13 | 開始されました | Robert W. Baird | Outperform |
| 2024-11-26 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-10-24 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-05-21 | 繰り返されました | Chardan Capital Markets | Buy |
| 2024-04-30 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-20 | 開始されました | H.C. Wainwright | Buy |
| 2023-02-27 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-02-15 | 開始されました | Oppenheimer | Outperform |
| 2023-01-26 | 開始されました | Guggenheim | Buy |
| 2022-07-20 | 開始されました | Chardan Capital Markets | Buy |
| 2022-07-12 | 開始されました | Raymond James | Outperform |
| 2020-10-12 | 開始されました | JP Morgan | Overweight |
| 2020-10-12 | 開始されました | Jefferies | Buy |
| 2020-10-12 | 開始されました | Piper Sandler | Overweight |
| 2020-10-12 | 開始されました | Stifel | Buy |
すべてを表示
Dyne Therapeutics Inc (DYN) 最新ニュース
Saturn V Capital Management LP Purchases Shares of 1,455,429 Dyne Therapeutics, Inc. $DYN - MarketBeat
Will Dyne Therapeutics Inc. stock benefit from automationStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? - AOL.com
JPMorgan Chase & Co. Has $29.39 Million Stock Holdings in Dyne Therapeutics, Inc. $DYN - MarketBeat
DYN: DMD and DM1 therapies near launch, with strong data and rapid commercialization plans - TradingView
Geode Capital Management LLC Has $21.46 Million Stock Position in Dyne Therapeutics, Inc. $DYN - MarketBeat
Franklin Resources Inc. Cuts Stock Holdings in Dyne Therapeutics, Inc. $DYN - MarketBeat
Bernstein Sees Favorable Risk-Reward for Dyne Therapeutics (DYN) Ahead of Major DYN-251 Data Release - Finviz
12 Best Upside Stocks to Buy Now - Insider Monkey
Ensign Peak Advisors Inc Has $2.53 Million Position in Dyne Therapeutics, Inc. $DYN - MarketBeat
Dyne (DYN) Jumps 41% as Jefferies Bets Firm to Benefit from Novartis-Avidity Merger - MSN
Dyne Therapeutics Stock Soars After Rival Avidity Biosciences Gets Acquired By Novartis - MSN
Bernstein raises Dyne Therapeutics stock price target to $21 on favorable risk-reward - Investing.com Canada
Why Dyne Therapeutics Stock Was Crushing it This Week - The Globe and Mail
Will Dyne Therapeutics Inc. stock see PE expansionMarket Sentiment Summary & Verified Technical Trade Signals - newser.com
Why Dyne Therapeutics Inc. stock is favored by top institutions - newser.com
Can Dyne Therapeutics Inc. stock reach $100 price targetWall Street Watch & Low Drawdown Investment Ideas - newser.com
Is Dyne Therapeutics Inc. stock attractive for long term wealth buildingWeekly Trading Summary & AI Optimized Trade Strategies - newser.com
Dyne Therapeutics Inc.’s volatility index tracking explained2025 Price Momentum & Low Risk Entry Point Guides - newser.com
Will Dyne Therapeutics Inc. stock deliver better than expected guidanceQuarterly Market Summary & Weekly Stock Breakout Alerts - newser.com
Will Dyne Therapeutics Inc. stock go up soon2025 Market Sentiment & Verified Technical Trade Signals - newser.com
Is Dyne Therapeutics Inc. reversing from oversold territoryIPO Watch & Reliable Breakout Forecasts - newser.com
Historical volatility pattern of Dyne Therapeutics Inc. visualized2025 Major Catalysts & Capital Protection Trading Alerts - newser.com
Dyne Therapeutics Inc. stock volume spike explainedInflation Watch & High Return Trade Guides - newser.com
Technical Reactions to DYN Trends in Macro Strategies - news.stocktradersdaily.com
Dyne Therapeutics (NASDAQ:DYN) Price Target Cut to $17.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
Technical analysis overview for Dyne Therapeutics Inc. stock2025 Macro Impact & Low Drawdown Momentum Ideas - newser.com
Why Dyne Therapeutics Inc. stock is seen as undervalued2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com
Dyne Therapeutics Inc (DYN) 財務データ
収益
当期純利益
現金流量
EPS
1.44%
0.91%
大文字化:
|
ボリューム (24 時間):